Aldeyra Therapeutics Inc. (ALDX)
NASDAQ: ALDX
· Real-Time Price · USD
5.38
0.08 (1.51%)
At close: Aug 15, 2025, 3:59 PM
5.38
0.00%
After-hours: Aug 15, 2025, 06:33 PM EDT
Aldeyra Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -19,696.8B | -9.93M | -15.81M | -15.11M | -16.85M | -8.08M | -4.75M | -8.19M | -8.99M | -15.62M | -12.9M | -14.55M | -17.78M | -16.79M | -15.75M | -15.79M | -14.94M | -11.29M |
Depreciation & Amortization | -715.72B | 60.91K | 64.37K | 62.99K | 61.63K | 60.63K | 66.47K | 65K | 64.34K | 66.97K | 66.64K | 65.31K | 64.01K | 62.74K | 61.27K | 68.35K | 66.69K | 67.86K |
Stock-Based Compensation | 2,420.6B | n/a | 1.26M | 3.23M | 1.94M | 1.55M | -800.34K | 789.22K | 1.57M | 4.19M | 2.82M | 2.24M | 1.29M | 1.94M | 984.47K | 1.42M | 2.32M | 2.38M |
Other Working Capital | 648.87K | -4.92M | 2.87M | 4.39M | 2.14M | -2.33M | 4.83M | -764.58K | -5.95M | -296.06K | -105.54K | -1.43M | -1.43M | 413.08K | 2.5M | 6.42M | 2.73M | -4.84M |
Other Non-Cash Items | -3,033B | 2.15M | -421.32K | -471K | -487.63K | -113.71K | -1.69M | 95.94K | 100.34K | 72.62K | 61.89K | 65.03K | 77.41K | 79.57K | 82.8K | 82.8K | 102.37K | 141.5K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 1.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.33M | -4.75M | 2.87M | 4.32M | 2.11M | -3.39M | 5.92M | -788.2K | -6.11M | 1.84M | -1.28M | -388.1K | -3.61M | 1.84M | 3.05M | 5.79M | 3.37M | -4.77M |
Operating Cash Flow | -21,024.9B | -12.47M | -12.04M | -7.97M | -13.22M | -9.97M | 500.44K | -8.02M | -13.36M | -9.44M | -11.23M | -12.57M | -19.96M | -12.87M | -11.58M | -8.43M | -9.07M | -13.47M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -3 | n/a | 4.00 | n/a | n/a | n/a | n/a | n/a | -16.32K | 7.81K | n/a | n/a | -7.81K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -40,263.7B | -15.71M | -21.56M | -14.74M | -30.24M | -30.38M | n/a | n/a | n/a | n/a | n/a | -4.98M | -29.94M | -58.02M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 47,000B | 23M | 20M | 20M | 12M | n/a | n/a | n/a | n/a | 30M | 27M | 24M | 12M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | n/a | 19.02K | -17.94K | -58.02M | -7.81B | n/a | n/a | -7.81K |
Investing Cash Flow | 6,736.3B | 7.29M | -1.56M | 5.26M | -18.24M | -30.38M | n/a | n/a | n/a | 30M | 27M | 19.02M | -17.94M | -58.03M | -7.81B | n/a | n/a | -7.81K |
Debt Repayment | n/a | n/a | -292.5K | n/a | n/a | n/a | -1.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1,002.8B | n/a | n/a | n/a | n/a | n/a | n/a | -532.95K | 5.29K | 52.56K | n/a | 1.2M | n/a | 23.32K | 4,684.8B | 63.78K | 606.84K | 4.01M |
Financial Cash Flow | 1,002.8B | 1M | 7.78K | -197.39K | n/a | 18.19K | -1.01M | -315.76K | 5.29K | 52.56K | n/a | 1.2M | n/a | 23.32K | 194,496.2B | 63.78K | 120.37M | 74.06M |
Net Cash Flow | 41,241.2B | -4.18M | -13.59M | -2.91M | -21.46M | -90.33M | -511.87K | -8.34M | -13.35M | 20.61M | 15.77M | 7.64M | -37.9M | -70.88M | -11.58M | -8.37M | 111.3M | 60.58M |
Free Cash Flow | -21,024.9B | -12.47M | -12.04M | -7.97M | -13.22M | -9.97M | 500.44K | -8.02M | -13.36M | -9.44M | -11.23M | -12.57M | -19.96M | -12.89M | -11.57M | -8.43M | -9.07M | -13.48M |